Search Results - "Karakousis, G"

Immune checkpoint blockade: an urgent call for biomarkers to help guide treatment by Karakousis, G.

“…Linked Article: Gambichler et al. Br J Dermatol 2020; 182:1214–1220…”
Get full text

The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma by Angeles, C. V., Wong, S. L., Karakousis, G.

“…Between 1980 and 2004, six randomized, controlled trials (RCTs) have been performed to evaluate the width of surgical margin excision for primary cutaneous…”
Get full text

ASO Author Reflections: Surgical Margins for Melanoma—What’s Next? by Angeles, C. V., Wong, S. L., Karakousis, G.

Get full text

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma by Sharon, C.E., Tortorello, G.N., Ma, K.L., Huang, A.C., Xu, X., Giles, L.R., McGettigan, S., Kreider, K., Schuchter, L.M., Mathew, A.J., Amaravadi, R.K., Gimotty, P.A., Miura, J.T., Karakousis, G.C., Mitchell, T.C.

“…While neoadjuvant immunotherapy for melanoma has shown promising results, the data have been limited by a relatively short follow-up time, with most studies…”
Get full text

Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study by Ecker, B.L, McMillan, M.T, Datta, J, Dempsey, D.T, Karakousis, G.C, Fraker, D.L, Drebin, J.A, Mamtani, R, Giantonio, B.J, Roses, R.E

“…Abstract Background Lymph node (LN) metastasis in patients with duodenal adenocarcinoma is associated with poor prognosis; however, the optimal extent of LN…”
Get full text

Sentinel lymph node positivity and overall survival in immunosuppressed patients with Merkel cell carcinoma: a national cohort study by Song, Y., Zheng, C., Shannon, A.B., Fraker, D.L., Miura, J.T., Karakousis, G.C.

Get full text

Preoperative radiotherapy in the management of retroperitoneal liposarcoma by Ecker, B. L., Peters, M. G., McMillan, M. T., Sinnamon, A. J., Zhang, P. J., Fraker, D. L., Levin, W. P., Roses, R. E., Karakousis, G. C.

“…Background Histological subtype influences both prognosis and patterns of treatment failure in retroperitoneal sarcoma. Previous studies on the efficacy of…”
Get full text

Regional Variation in Total Cost of A Homogenous Surgical Procedure by Reinke, C.E, Bansal, N, Meise, C, Karakousis, G, Fraker, D, Kelz, R.R

Get full text

Title: Does Variation in Cost of A Surgical Procedure Equate To Differences in the Value of the Care Delivered? by Reinke, C.E, Bansal, N, Meise, C, Karakousis, G, Fraker, D, Kelz, R.R

Get full text

The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases: A multicenter cohort study by Olofsson Bagge, Roger, Holmberg, Carl Jacob, Hieken, Tina J., Zager, Jonathan S., Long, Georgina V., Van Akkooi, Alexander Christopher Jonathan, Karakousis, Giorgos C, Pallan, Lalit, Vetto, John T., Gyorki, David E., Ascierto, Paolo Antonio, Dummer, Reinhard, Hui, Jane Yuet Ching, Schachter, Jacob, Helgadottir, Hildur, Kroon, Hidde, Rothermel, Luke Daniel, Carlino, Matteo S., Broman, Kristy Kummerow, Ny, Lars

“…9569 Background: Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option,…”
Get full text

Soft Tissue Sarcoma Diagnosed Subsequent to Lymphoma is Associated With Prior Radiotherapy and Decreased Survival by Baldwin, K.M, Katz, S.C, Karakousis, G, Singer, S, Bruglino, A, Brennan, M.F

Get full text

The beta protein of phage λ promotes strand exchange by Li, Z, Karakousis, G, Chiu, S.K, Reddy, G, Radding, C.M

“…Bacteriophage λ encodes a 28 kDa protein called β that binds to single-stranded DNA and promotes the renaturation of complementary single strands. β Protein…”
Get full text

The beta protein of phage λ binds preferentially to an intermediate in DNA renaturation by Karakousis, G, Ye, N, Li, Z, Chiu, S.K, Reddy, G, Radding, C.M

“…Phage λ encodes two recombination proteins that are required for homologous recombination in a recA − host strain. Of these two recombination proteins, one is…”
Get full text

315 Acral lentiginous melanoma: Presentation and outcomes in the era of effective melanoma therapy by Straker, R.J., Shannon, A., Chu, E., Karakousis, G., Ming, M.E.

Get full text

Ablation Versus Sublobar Resection and Stereotactic Body Radiation Therapy for Early Stage Non–Small Cell Lung Cancer: An Analysis of 64,505 Patients from the National Cancer Database by Su, C., Wu, J., Bai, H.X., Zhang, P.J., Karakousis, G., Hunt, S.J., Zhang, Z.

Get full text

Mitotic rate as a predictor for sentinel lymph node positivity in patients with thin melanomas by Kesmodel, S. B., Karakousis, G. C., Terhune, K. P., Canter, R. J., Wahl, P., Gimotty, P., Guerry, D., Fraker, D. L., Czerniecki, B. J., Spitz, F. R.

Get full text

Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2) by Broman, Kristy Kummerow, Hughes, Tasha, Dossett, Lesly, Sun, James, Kirichenko, Dennis, Carr, Michael J., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda A. G., Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey M., Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew C., Lowe, Michael C., Olofsson Bagge, Roger, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Juri, Teras, Roland M., Farrow, Norma E., Beasley, Georgia, Hui, Jane Yuet Ching, Been, Lukas, Kruijff, Schelto, Kim, Youngchul, Naqvi, Syeda Mahrukh Hussnain, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

“…Background For patients with sentinel lymph node (SLN)‐positive cutaneous melanoma, the Second Multicenter Selective Lymphadenectomy trial demonstrated…”
Get full text

03:00 PM Abstract No. 83 Cryoablation therapy compared with thermal ablation for clinical T1a renal cell carcinoma: a National Cancer Data Base study by Xi, I., Chang, J., Wu, J., Zhang, Z., Soulen, M., Hunt, S., Karakousis, G., Zhang, P., Reddy, S., Bai, H., Stavropoulos, S.

Get full text

Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis by Broman, Kristy K., Hughes, Tasha M., Dossett, Lesly A., Sun, James, Carr, Michael J., Kirichenko, Dennis A., Sharma, Avinash, Bartlett, Edmund K., Nijhuis, Amanda AG, Thompson, John F., Hieken, Tina J., Kottschade, Lisa, Downs, Jennifer, Gyorki, David E., Stahlie, Emma, van Akkooi, Alexander, Ollila, David W., Frank, Jill, Song, Yun, Karakousis, Giorgos, Moncrieff, Marc, Nobes, Jenny, Vetto, John, Han, Dale, Farma, Jeffrey, Deneve, Jeremiah L., Fleming, Martin D., Perez, Matthew, Baecher, Kirsten, Lowe, Michael, Bagge, Roger Olofsson, Mattsson, Jan, Lee, Ann Y., Berman, Russell S., Chai, Harvey, Kroon, Hidde M., Teras, Roland M., Teras, Juri, Farrow, Norma E., Beasley, Georgia M., Hui, Jane YC, Been, Lukas, Kruijff, Schelto, Boulware, David, Sarnaik, Amod A., Sondak, Vernon K., Zager, Jonathan S.

“…In sentinel lymph node (SLN)-positive melanoma, two randomized trials demonstrated equivalent melanoma-specific survival with nodal surveillance vs completion…”
Get full text

Tertiary Hyperparathyroidism in Kidney Transplant Recipients: Characteristics of Patients Selected for Different Treatment Strategies by YANG, Rachel L, FREEMAN, Kate, REINKE, Caroline E, FRAKER, Douglas L, KARAKOUSIS, Giorgos C, KELZ, Rachel R, DOYLE, Alden M

“…Several treatment options exist for kidney transplant patients with tertiary hyperparathyroidism. However, the decision to endorse observation (OBS), medical…”
Get full text